Elite Pharmaceuticals ELTP
OTC ELTP
$0.35 +0.03 (+10.69%)
As of: Nov 16, 2026 · 12:13 PM EST

Elite Pharmaceuticals (ELTP) EBITDA (2009 - 2026)

Updated

Elite Pharmaceuticals (ELTP) posted EBITDA of $10.31 million for fiscal Q2 2027 (quarter ended Sep 30, 2026), up 19.7% from $8.61 million a year earlier and up 30.5% from the prior quarter.

Analysis

Elite Pharmaceuticals (ELTP) EBITDA (2009 - 2026) Analysis & Trends

For the trailing twelve months through Sep 30, 2026, EBITDA at Elite Pharmaceuticals was $38.16 million, down 12.9% year-over-year; for FY2026 (ended Mar 31, 2026), it was $50.66 million, up 138.0% from FY2025.

  • Annual EBITDA has increased for three consecutive fiscal years, with a five-year compound annual growth rate of 71.5% (FY2021 to FY2026).
  • In prior fiscal years, Elite Pharmaceuticals' EBITDA was $21.29 million in FY2025 (+75.1%), $12.16 million in FY2024 (+145.4%), $4.95 million in FY2023 (-21.1%) and $6.28 million in FY2022 (+83.7%).
  • Quarterly EBITDA has run from a low of -$42,808 in fiscal Q4 2023 to a high of $22.09 million in fiscal Q1 2026 over five years.
  • On a year-over-year basis, EBITDA increased in five of the last eight quarters, with growth averaging 140.3%.
  • The strongest year-over-year quarter for EBITDA in the past five years was fiscal Q3 2026, with growth of 514.3%; the weakest was fiscal Q1 2027, with a decline of 64.3%.
  • According to Business Quant data, EBITDA for the three prior fiscal quarters was $7.9 million (Q1 2027), $10.56 million (Q4 2026) and $9.4 million (Q3 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA (Qtr)
1 Eli Lilly 1,293.04 Bn 1,266.66 Bn 20.46 Bn 8.95 Bn
2 Johnson & Johnson 686.83 Bn 606.69 Bn 17.30 Bn 8.30 Bn
3 AbbVie 525.76 Bn 493.76 Bn 13.12 Bn 8.16 Bn
4 Merck 362.73 Bn 325.68 Bn 13.19 Bn 7.34 Bn
5 Novartis Ag 313.98 Bn 287.22 Bn - -
6 Astrazeneca 287.17 Bn 260.69 Bn 13.26 Bn 5.99 Bn
7 Amgen 253.65 Bn 205.30 Bn 7.58 Bn 4.83 Bn
8 Gilead Sciences 210.81 Bn 185.92 Bn 6.73 Bn 4.20 Bn
9 Pfizer 165.44 Bn 112.80 Bn 12.56 Bn 7.05 Bn
10 Elite Pharmaceuticals 373.77 Mn 247.18 Mn 15.99 Mn 10.31 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 10.31 Mn
Jun 30, 2026 7.90 Mn
Mar 31, 2026 10.56 Mn
Dec 31, 2025 9.40 Mn
Sep 30, 2025 8.61 Mn
Jun 30, 2025 22.09 Mn
Mar 31, 2025 11.56 Mn
Dec 31, 2024 1.53 Mn
Sep 30, 2024 3.83 Mn
Jun 30, 2024 4.29 Mn
Mar 31, 2024 4.10 Mn
Dec 31, 2023 3.87 Mn
Sep 30, 2023 2.25 Mn
Jun 30, 2023 1.93 Mn
Mar 31, 2023 -42,808.00
Dec 31, 2022 2.28 Mn
Sep 30, 2022 1.40 Mn
Jun 30, 2022 1.32 Mn
Mar 31, 2022 1.15 Mn
Dec 31, 2021 2.13 Mn
API Access

Elite Pharmaceuticals EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda&ticker=ELTP&period=max&api_key=YOUR_API_KEY